“…In tumor tissue, especially in high grade malignant brain tumors, the content of mobile proteins and peptides is considerably elevated. This correlates with APTw intensity values and thus APTw imaging can be used for tumor characterization and diagnosis (Togao et al, 2014; Jiang et al, 2016, 2017a,b, 2019; Ma et al, 2016; Park et al, 2016; Su et al, 2017; Yu et al, 2017; Dreher et al, 2018, 2019; Van de Ven and Keupp, 2018; Zhou et al, 2019). Hence APTw imaging allows the differentiation of low-grade gliomas from high grade gliomas (Jiang et al, 2017a; Su et al, 2017; Van de Ven and Keupp, 2018), the prediction of the isocitrate dehydrogenase (IDH) mutation status in gliomas (Jiang et al, 2017b; Dreher et al, 2018), the differentiation of high grade gliomas from primary central nervous system lymphomas (Jiang et al, 2016) and from metastases (Yu et al, 2017) and the differentiation of tumor progression and treatment effects (Ma et al, 2016; Van de Ven and Keupp, 2018; Jiang et al, 2019).…”